IBDEI220 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,684,0)
 ;;=PHYSICAL THERAPY^5^54
 ;;^UTILITY(U,$J,358.4,685,0)
 ;;=COUNSELING^2^55
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=DIABETES W/O COMPLICATION^3^55
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=OVERWEIGHT/OBESITY^5^55
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=BODY MASS INDEX (BMI)^1^55
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=OTHER^4^55
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=NEW PATIENT^2^56
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=ESTABLISHED PATIENT^1^56
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=CONSULTATIONS^3^56
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=ESTABLISHED PATIENT^1^57
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=CONSULTATIONS/OPINIONS^2^57
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=NEWPATIENTS^3^57
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=CEREBROVASCULAR DIS^2^58
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^12^58
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=HEADACHE^5^58
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=DIZZINESS^3^58
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=NEURODEGENERATIVE DIS^8^58
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=PAIN^11^58
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=NEUROPATHIES^9^58
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=ENCEPHALOPATHY^4^58
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=SPINAL CONDITIONS^13^58
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=VISION DISTURBANCES^15^58
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=MOVEMENT DISORDERS^6^58
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=OTHER^10^58
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=CARDIAC DISORDERS^1^58
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=NEOPLASMS^7^58
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=SYMPTOMS^14^58
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=NEUROLOGY/SEIZURE^7^59
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=EEG^4^59
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=SLEEP TESTING^9^59
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=MUSCLE TESTING/EMG^6^59
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=EVOKED POTENTIAL^5^59
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=BIOPSY^2^59
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=AUTONOMIC FUNCTION TESTS^1^59
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=STEREOTACTIC^10^59
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=EDUCATION^3^59
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=NEUROSTIMULATORS^8^59
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=OB/GYN PROCEDURES^1^60
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=INJECTABLES/IMMUNIZATIONS^5^60
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=INJECTION/IMMUNIZATION ADMIN^4^60
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=FOREIGN BODY^3^60
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=UA/FINGERSTICK^12^60
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=FLUSHES^2^60
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=OTHER PROCEDURES^7^60
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=MATERNAL CARE^6^60
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=PREVENTIVE COUNSELING^8^60
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=PREVENTIVE-ESTAB PT^9^60
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=PREVENTIVE-NEW PT^10^60
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=SUPPLIES^11^60
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=NEW PATIENT^2^61
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=ESTABLISHED PATIENT^1^61
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=CONSULTATIONS^3^61
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=GASTROINTESTINAL^3^62
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=GENITOURINARY & RENAL^2^62
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=GYNECOLOGICAL/BREAST^1^62
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=PREGNANCY-COMPLICATIONS^4^62
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=PREGNANCY-FETAL ABNORMALITY^5^62
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=PREGNANCY-HYPERTENSION^6^62
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=PREGNANCY-INFECTIONS BREAST/NIPPLE^7^62
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=PREGNANCY-LATE PREGNANCY^8^62
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=PREGNANCY-PUERPERAL INFECTIONS^14^62
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=PREGNANCY-MULTIPLE GESTATIONS^9^62
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=PREGNANCY-OTH COMP OF PUERPERIUM^11^62
 ;;
 ;;$END ROU IBDEI220
